Modern antihyperglycemic therapy: safety and efficacy of glimepiride

Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due t...

Full description

Saved in:
Bibliographic Details
Main Authors: Lyudmila Alexandrovna Ruyatkina, Maksim Yur'evich Sorokin
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-06-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5525
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849327338809982976
author Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
author_facet Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
author_sort Lyudmila Alexandrovna Ruyatkina
collection DOAJ
description Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning.
format Article
id doaj-art-7e0a54b9cd51417cbf3ed787ad5c41a0
institution Kabale University
issn 2072-0351
2072-0378
language English
publishDate 2012-06-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj-art-7e0a54b9cd51417cbf3ed787ad5c41a02025-08-20T03:47:54ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-06-01152899710.14341/2072-0351-55255483Modern antihyperglycemic therapy: safety and efficacy of glimepirideLyudmila Alexandrovna Ruyatkina0Maksim Yur'evich Sorokin1Novosibirsk State Medical University, NovosibirskNovosibirsk City Hospital №1, NovosibirskCurrent review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning.https://www.dia-endojournals.ru/jour/article/view/5525diabetes mellitus type 2sulphonylureaglimepiridecardioprotectionantihyperglycemic safety
spellingShingle Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
Сахарный диабет
diabetes mellitus type 2
sulphonylurea
glimepiride
cardioprotection
antihyperglycemic safety
title Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_full Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_fullStr Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_full_unstemmed Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_short Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_sort modern antihyperglycemic therapy safety and efficacy of glimepiride
topic diabetes mellitus type 2
sulphonylurea
glimepiride
cardioprotection
antihyperglycemic safety
url https://www.dia-endojournals.ru/jour/article/view/5525
work_keys_str_mv AT lyudmilaalexandrovnaruyatkina modernantihyperglycemictherapysafetyandefficacyofglimepiride
AT maksimyurevichsorokin modernantihyperglycemictherapysafetyandefficacyofglimepiride